Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gossamer Bio Inc (NQ: GOSS ) 1.090 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1 Open 1.090 Bid (Size) 1.090 (1) Ask (Size) 1.150 (6) Prev. Close 1.090 Today's Range 1.090 - 1.090 52wk Range 0.4525 - 1.600 Shares Outstanding 75,993,532 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says June 25, 2024 Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary arterial hypertension. Seralutinib shows potential in underserved markets. Via Benzinga Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying June 25, 2024 Via Benzinga Performance YTD +12.37% +12.37% 1 Month +7.92% +7.92% 3 Month +62.69% +62.69% 6 Month +36.40% +36.40% 1 Year -13.49% -13.49% More News Read More Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 21, 2024 Via Benzinga The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street June 13, 2024 Via InvestorPlace HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know January 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session June 11, 2024 Via Benzinga Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 07, 2024 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference May 14, 2024 From Gossamer Bio, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session May 13, 2024 Via Benzinga Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 10, 2024 From Gossamer Bio, Inc. Via Business Wire GOSS Stock Earnings: Gossamer Bio Misses EPS for Q1 2024 May 07, 2024 Via InvestorPlace Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update May 07, 2024 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide May 06, 2024 Via Benzinga Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications May 06, 2024 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine May 03, 2024 From Gossamer Bio, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session April 25, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session April 05, 2024 Via Benzinga Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors March 12, 2024 From Gossamer Bio, Inc. Via Business Wire Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know March 06, 2024 Via Benzinga GOSS Stock Earnings: Gossamer Bio Meets EPS for Q4 2023 March 05, 2024 Via InvestorPlace Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update March 05, 2024 From Gossamer Bio, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's Intraday Session February 20, 2024 Via Benzinga 7 Micro-Cap Stocks That Could Majorly Surprise Investors January 31, 2024 Via InvestorPlace Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) January 08, 2024 From Gossamer Bio, Inc. Via Business Wire Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session December 18, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
